Development of Quality Measures in Cirrhosis by the Practice Metrics Committee of the American Association for the Study of Liver Diseases

Fasiha Kanwal, Elliot B. Tapper, Chanda Ho, Sumeet K. Asrani, Nadia Ovchinsky, John Poterucha, Avegail Flores, Victor Ankoma-Sey, Bruce Luxon, Michael Volk

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Health care delivery is increasingly evaluated according to quality measures, yet such measures are underdeveloped for cirrhosis. The Practice Metrics Committee of the American Association for the Study of Liver Diseases was charged with developing explicit process-based and outcome-based measures for adults with cirrhosis. We identified candidate measures from comprehensive reviews of the literature and input from expert clinicians and patient focus groups. We conducted an 11-member expert clinician panel and used a modified Delphi method to systematically identify a set of quality measures in cirrhosis. Among 119 candidate measures, 46 were identified as important measures to define the quality of cirrhosis care, including 26 process measures, 7 clinical outcome measures, and 13 patient-reported outcome measures. The final process measures captured care processes for ascites (n = 5), varices/bleeding (n = 7), hepatic encephalopathy (n = 4), hepatocellular cancer (HCC) screening (n = 1), liver transplantation evaluation (n = 2), and other care (n = 7). Clinical outcome measures included survival, variceal bleeding and rebleeding, early-stage HCC, liver-related hospitalization, and rehospitalization within 7 and 30 days. Patient-reported outcome measures covered physical symptoms, physical function, mental health, general function, cognition, social life, and satisfaction with care. The final list of patient-reported outcomes was validated in 79 patients with cirrhosis from nine institutions in the United States. Conclusion: We developed an explicit set of evidence-based quality measures for adult patients with cirrhosis. These measures are a tool for providers and institutions to evaluate their care quality, drive quality improvement, and deliver high-value cirrhosis care. The quality measures are intended to be applicable in any clinical care setting in which care for patients with cirrhosis is provided.

Original languageEnglish (US)
Pages (from-to)1787-1797
Number of pages11
JournalHepatology
Volume69
Issue number4
DOIs
StatePublished - Apr 1 2019
Externally publishedYes

Fingerprint

Fibrosis
Liver Neoplasms
Process Assessment (Health Care)
Quality of Health Care
Outcome Assessment (Health Care)
Hemorrhage
Hepatic Encephalopathy
Varicose Veins
Quality Improvement
Focus Groups
Early Detection of Cancer
Ascites
Liver Transplantation
Cognition
Patient Care
Mental Health
Hospitalization
Delivery of Health Care
Survival
Patient Reported Outcome Measures

ASJC Scopus subject areas

  • Hepatology

Cite this

Development of Quality Measures in Cirrhosis by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. / Kanwal, Fasiha; Tapper, Elliot B.; Ho, Chanda; Asrani, Sumeet K.; Ovchinsky, Nadia; Poterucha, John; Flores, Avegail; Ankoma-Sey, Victor; Luxon, Bruce; Volk, Michael.

In: Hepatology, Vol. 69, No. 4, 01.04.2019, p. 1787-1797.

Research output: Contribution to journalArticle

Kanwal, F, Tapper, EB, Ho, C, Asrani, SK, Ovchinsky, N, Poterucha, J, Flores, A, Ankoma-Sey, V, Luxon, B & Volk, M 2019, 'Development of Quality Measures in Cirrhosis by the Practice Metrics Committee of the American Association for the Study of Liver Diseases', Hepatology, vol. 69, no. 4, pp. 1787-1797. https://doi.org/10.1002/hep.30489
Kanwal, Fasiha ; Tapper, Elliot B. ; Ho, Chanda ; Asrani, Sumeet K. ; Ovchinsky, Nadia ; Poterucha, John ; Flores, Avegail ; Ankoma-Sey, Victor ; Luxon, Bruce ; Volk, Michael. / Development of Quality Measures in Cirrhosis by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. In: Hepatology. 2019 ; Vol. 69, No. 4. pp. 1787-1797.
@article{7bcb0f469b1d4c388dfdb9f2c77af26c,
title = "Development of Quality Measures in Cirrhosis by the Practice Metrics Committee of the American Association for the Study of Liver Diseases",
abstract = "Health care delivery is increasingly evaluated according to quality measures, yet such measures are underdeveloped for cirrhosis. The Practice Metrics Committee of the American Association for the Study of Liver Diseases was charged with developing explicit process-based and outcome-based measures for adults with cirrhosis. We identified candidate measures from comprehensive reviews of the literature and input from expert clinicians and patient focus groups. We conducted an 11-member expert clinician panel and used a modified Delphi method to systematically identify a set of quality measures in cirrhosis. Among 119 candidate measures, 46 were identified as important measures to define the quality of cirrhosis care, including 26 process measures, 7 clinical outcome measures, and 13 patient-reported outcome measures. The final process measures captured care processes for ascites (n = 5), varices/bleeding (n = 7), hepatic encephalopathy (n = 4), hepatocellular cancer (HCC) screening (n = 1), liver transplantation evaluation (n = 2), and other care (n = 7). Clinical outcome measures included survival, variceal bleeding and rebleeding, early-stage HCC, liver-related hospitalization, and rehospitalization within 7 and 30 days. Patient-reported outcome measures covered physical symptoms, physical function, mental health, general function, cognition, social life, and satisfaction with care. The final list of patient-reported outcomes was validated in 79 patients with cirrhosis from nine institutions in the United States. Conclusion: We developed an explicit set of evidence-based quality measures for adult patients with cirrhosis. These measures are a tool for providers and institutions to evaluate their care quality, drive quality improvement, and deliver high-value cirrhosis care. The quality measures are intended to be applicable in any clinical care setting in which care for patients with cirrhosis is provided.",
author = "Fasiha Kanwal and Tapper, {Elliot B.} and Chanda Ho and Asrani, {Sumeet K.} and Nadia Ovchinsky and John Poterucha and Avegail Flores and Victor Ankoma-Sey and Bruce Luxon and Michael Volk",
year = "2019",
month = "4",
day = "1",
doi = "10.1002/hep.30489",
language = "English (US)",
volume = "69",
pages = "1787--1797",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Development of Quality Measures in Cirrhosis by the Practice Metrics Committee of the American Association for the Study of Liver Diseases

AU - Kanwal, Fasiha

AU - Tapper, Elliot B.

AU - Ho, Chanda

AU - Asrani, Sumeet K.

AU - Ovchinsky, Nadia

AU - Poterucha, John

AU - Flores, Avegail

AU - Ankoma-Sey, Victor

AU - Luxon, Bruce

AU - Volk, Michael

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Health care delivery is increasingly evaluated according to quality measures, yet such measures are underdeveloped for cirrhosis. The Practice Metrics Committee of the American Association for the Study of Liver Diseases was charged with developing explicit process-based and outcome-based measures for adults with cirrhosis. We identified candidate measures from comprehensive reviews of the literature and input from expert clinicians and patient focus groups. We conducted an 11-member expert clinician panel and used a modified Delphi method to systematically identify a set of quality measures in cirrhosis. Among 119 candidate measures, 46 were identified as important measures to define the quality of cirrhosis care, including 26 process measures, 7 clinical outcome measures, and 13 patient-reported outcome measures. The final process measures captured care processes for ascites (n = 5), varices/bleeding (n = 7), hepatic encephalopathy (n = 4), hepatocellular cancer (HCC) screening (n = 1), liver transplantation evaluation (n = 2), and other care (n = 7). Clinical outcome measures included survival, variceal bleeding and rebleeding, early-stage HCC, liver-related hospitalization, and rehospitalization within 7 and 30 days. Patient-reported outcome measures covered physical symptoms, physical function, mental health, general function, cognition, social life, and satisfaction with care. The final list of patient-reported outcomes was validated in 79 patients with cirrhosis from nine institutions in the United States. Conclusion: We developed an explicit set of evidence-based quality measures for adult patients with cirrhosis. These measures are a tool for providers and institutions to evaluate their care quality, drive quality improvement, and deliver high-value cirrhosis care. The quality measures are intended to be applicable in any clinical care setting in which care for patients with cirrhosis is provided.

AB - Health care delivery is increasingly evaluated according to quality measures, yet such measures are underdeveloped for cirrhosis. The Practice Metrics Committee of the American Association for the Study of Liver Diseases was charged with developing explicit process-based and outcome-based measures for adults with cirrhosis. We identified candidate measures from comprehensive reviews of the literature and input from expert clinicians and patient focus groups. We conducted an 11-member expert clinician panel and used a modified Delphi method to systematically identify a set of quality measures in cirrhosis. Among 119 candidate measures, 46 were identified as important measures to define the quality of cirrhosis care, including 26 process measures, 7 clinical outcome measures, and 13 patient-reported outcome measures. The final process measures captured care processes for ascites (n = 5), varices/bleeding (n = 7), hepatic encephalopathy (n = 4), hepatocellular cancer (HCC) screening (n = 1), liver transplantation evaluation (n = 2), and other care (n = 7). Clinical outcome measures included survival, variceal bleeding and rebleeding, early-stage HCC, liver-related hospitalization, and rehospitalization within 7 and 30 days. Patient-reported outcome measures covered physical symptoms, physical function, mental health, general function, cognition, social life, and satisfaction with care. The final list of patient-reported outcomes was validated in 79 patients with cirrhosis from nine institutions in the United States. Conclusion: We developed an explicit set of evidence-based quality measures for adult patients with cirrhosis. These measures are a tool for providers and institutions to evaluate their care quality, drive quality improvement, and deliver high-value cirrhosis care. The quality measures are intended to be applicable in any clinical care setting in which care for patients with cirrhosis is provided.

UR - http://www.scopus.com/inward/record.url?scp=85062833780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062833780&partnerID=8YFLogxK

U2 - 10.1002/hep.30489

DO - 10.1002/hep.30489

M3 - Article

C2 - 30586188

AN - SCOPUS:85062833780

VL - 69

SP - 1787

EP - 1797

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 4

ER -